Osteoporosis

• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Bad Nauheim, Germany
• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Frankfurt, Germany
• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Hamburg, Germany
• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Heinsberg, Germany

• Duquesne University School of Pharmacy Center for Pharmacy Care — Pittsburgh, Pennsylvania, United States

• Vakif Gureba Training & Research Hospital — Istanbul, Turkey (Türkiye)

• Bio-Kinetic Clinical Applications, Inc. — Springfield, Missouri, United States

Not specified

• University of Alberta — Edmonton, Alberta, Canada

• The Center for Behavioral Epidemiology and Community Health at the Graduate School of Public Health at San Diego State University — San Diego, California, United States

• Novartis Investigative Site — Cologne, Germany
• Novartis Investigative Site — Deggendorf, Germany
• Novartis Investigative Site — Frankfurt am Main, Germany
• Novartis Investigative Site — Freiburg im Breisgau, Germany

• School of Medicine - Division of Rheumatology — São Paulo, Brazil

• Medical Dpt. B, University Hospital of Northern Norway — Tromsø, Norway